Mortality benefits and overdiagnosis estimates for women attending breast screening.
作者信息
Ormiston-Smith N, Scowcroft H, Thomson C S
出版信息
Br J Cancer. 2013 Jun 11;108(11):2413-4. doi: 10.1038/bjc.2013.260. Epub 2013 Jun 6.
Abstract
摘要
相似文献
1
Mortality benefits and overdiagnosis estimates for women attending breast screening.参加乳房筛查的女性的死亡率益处及过度诊断估计值。
Br J Cancer. 2013 Jun 11;108(11):2413-4. doi: 10.1038/bjc.2013.260. Epub 2013 Jun 6.
2
Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.欧洲乳腺癌 X 光筛查中的过度诊断：文献综述。
J Med Screen. 2012;19 Suppl 1:42-56. doi: 10.1258/jms.2012.012082.
3
Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.人群为基础的乳腺摄影筛检计划启动后的乳癌发生率与过度诊断的评估。
CMAJ. 2013 Jul 9;185(10):E492-8. doi: 10.1503/cmaj.121791. Epub 2013 Jun 10.
4
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.筛查性乳房 X 光摄影术所致浸润性乳腺癌过度诊断的评估。
Cancer Causes Control. 2010 Feb;21(2):275-82. doi: 10.1007/s10552-009-9459-z. Epub 2009 Nov 6.
5
Women's views on overdiagnosis in breast cancer screening: a qualitative study.女性对乳腺癌筛查过度诊断的看法：一项定性研究。
BMJ. 2013 Jan 23;346:f158. doi: 10.1136/bmj.f158.
6
Breast cancer incidence trends in Norway and estimates of overdiagnosis.挪威乳腺癌发病率趋势及过度诊断估计
J Med Screen. 2017 Jun;24(2):83-91. doi: 10.1177/0969141316668379. Epub 2016 Oct 17.
7
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.癌症筛查中过长的领先时间导致了对过度诊断的严重低估。
Br J Cancer. 2013 Oct 1;109(7):2014-9. doi: 10.1038/bjc.2013.427. Epub 2013 Aug 20.
8
Interpreting overdiagnosis estimates in population-based mammography screening.基于人群的乳腺 X 光筛查中过度诊断的评估解读。
Epidemiol Rev. 2011;33(1):111-21. doi: 10.1093/epirev/mxr009. Epub 2011 Jun 27.
9
Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.基于人群的乳腺癌筛查与基于风险和普遍的乳房 X 光筛查与临床乳房检查比较：对 1429890 名台湾妇女的倾向评分分析。
JAMA Oncol. 2016 Jul 1;2(7):915-21. doi: 10.1001/jamaoncol.2016.0447.
10
Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.在乳腺癌和前列腺癌筛查中，研究特征和方法对过度诊断估计的影响。
Ann Intern Med. 2013 Jun 4;158(11):831-8. doi: 10.7326/0003-4819-158-11-201306040-00008.
引用本文的文献
1
Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation.使用离散事件模拟评估巴斯克地区乳腺癌筛查项目的健康益处和危害。
BMC Cancer. 2015 Oct 12;15:671. doi: 10.1186/s12885-015-1700-4.
本文引用的文献
1
The benefits and harms of breast cancer screening: an independent review.乳腺癌筛查的益处与危害：一项独立综述。
Br J Cancer. 2013 Jun 11;108(11):2205-40. doi: 10.1038/bjc.2013.177. Epub 2013 Jun 6.
2
The benefits and harms of breast cancer screening: an independent review.乳腺癌筛查的获益与危害：一项独立评审。
Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30.
3
Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.服务筛查的有效性：一项评估乳腺癌死亡率降低情况的病例对照研究。
Br J Cancer. 2008 Aug 5;99(3):423-7. doi: 10.1038/sj.bjc.6604532.
4
Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK.英国北德比郡的社会经济剥夺、出行距离、服务地点与乳腺癌筛查的接受情况
J Epidemiol Community Health. 2006 Mar;60(3):208-12. doi: 10.1136/jech.200X.038398.
5
Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.65岁之后的乳腺钼靶筛查：降低乳腺癌死亡率的证据
Int J Cancer. 1996 Jun 11;66(6):727-31. doi: 10.1002/(SICI)1097-0215(19960611)66:6<727::AID-IJC3>3.0.CO;2-1.
6
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.通过病例对照研究对一项非随机研究（DOM项目）中的乳腺癌筛查进行评估。
Lancet. 1984 Jun 2;1(8388):1224-6. doi: 10.1016/s0140-6736(84)91704-5.
Zotero 插件